Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of

Authors :: Paul, Mésange
Anaïs, Bouygues
Nathalie, Ferrand
Michèle, Sabbah
Alexandre E, Escargueil
Ariel, Savina
Benoist, Chibaudel
Christophe, Tournigand
Thierry, André
Aimery, de Gramont
Annette K, Larsen
Source :: Clinical cancer research : an official journal of the American Association for Cancer Research. 24(11)
Publication Year :: 2017

Subjects :: Proto-Oncogene Proteins B-raf
Neovascularization, Pathologic
Drug Synergism
Prognosis
Xenograft Model Antitumor Assays
Bevacizumab
Disease Models, Animal
Erlotinib Hydrochloride
Mice
Treatment Outcome
Cell Line, Tumor
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
ras Proteins
Animals
Humans
Colorectal Neoplasms
Signal Transduction

ISSN :: 15573265
Volume :: 24
Issue :: 11
Database :: OpenAIRE
Journal :: Clinical cancer research : an official journal of the American Association for Cancer Research
Accession number :: edsair.pmid..........cb01fa0b766c3a11a2ae4deee9a8a457

Tools